Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 3,652,000	$ 7,280,000
Accounts receivable, net of allowance for doubtful accounts of $156,000 at March 31, 2022 and December 31, 2021	2,175,000	733,000
Inventories	5,893,000	5,373,000
Prepaid expenses and other current assets	1,474,000	1,578,000
Total current assets	13,194,000	14,964,000
Inventories non-current, net	1,197,000	1,709,000
Equipment and leasehold improvements, net	1,224,000	1,261,000
Right-of-use operating lease assets, net	525,000	571,000
Goodwill	781,000	781,000
Other intangible assets, net	1,310,000	1,318,000
Other assets	48,000	48,000
Total assets	18,279,000	20,652,000
Current liabilities:
Accounts payable	1,866,000	1,280,000
Accrued payroll and related expenses	456,000	348,000
Deferred revenue – short-term	1,159,000	719,000
Notes Payable, Related Parties, Current	10,000,000
Interest payable – related party	153,000	2,231,000
Convertible promissory note, net	1,000,000	813,000
Other current liabilities	843,000	957,000
Total current liabilities	15,477,000	6,348,000
Convertible promissory note – related party, net		9,245,000
Operating lease obligations – long-term	338,000	398,000
Deferred revenue – long-term	1,163,000	1,244,000
Other noncurrent liabilities	19,000	20,000
Total liabilities	16,997,000	17,255,000
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.001 par value; 2,000,000 shares authorized, none outstanding	0	0
Common stock, $0.001 par value; 350,000,000 shares authorized; 12,829,877 issued and outstanding (11,911,784 at December 31, 2021)	13,000	12,000
Additional paid in capital	258,614,000	268,447,000
Accumulated deficit	(256,833,000)	(264,662,000)
Accumulated other comprehensive loss	45,000	31,000
Total ThermoGenesis Holdings, Inc. stockholders’ equity	1,839,000	3,828,000
Noncontrolling interests	(557,000)	(431,000)
Total equity	1,282,000	3,397,000
Total liabilities and equity	$ 18,279,000	$ 20,652,000